This article reviews a recent study on the use of Tranexamic Acid (TXA) in traumatic brain injury (TBI) patients with intracranial hemorrhage (ICH), focusing on prehospital care.
2g or 1+1g Tranexamic Acid (TXA) in traumatic brain injury? Read More
Our conference report from the 11th Kongress der Arbeitsgemeinschaft fur Notfallmedizin in Graz Austria in 2024. r@stemlyns Blog themes on trauma, cardiac arrest and research . #FOAMed
11th Kongress der Arbeitsgemeinschaft fur Notfallmedizin Read More
Despite the socializing and “Stand-Up Science” events that ran pretty late into the night, there was no holding back the full cohort of attendees for Day 2 of LTC. Let’s
What did we learn at the London Trauma Conference 2022 – Part Two Read More
Part 1 review of the 2022 London Trauma Conference with Zaf @resusone #FOAMed @stemlyns
What did we learn at the London Trauma Conference 2022? – Part One Read More
I’m writing this blog post after listening to the ever excellent Scott Weingart on the EMCrit podcast in discussion with the authors of this paper, to which I highly recommend
Hypocalcaemia, Trauma and Major Transfusion. St Emlyn’s Read More
Bleeding trauma patients present a couple of challenges to us in the Emergency Department. Increasingly, our aging population continues to engage in energetic daily pursuits while increasing numbers are prescribed
JC: Blood Products in Trauma – What’s the Best (I)TACTIC? Read More
Tranexamic Acid (TXA) is a mainstay of trauma management. CRASH 2 (2) demonstrated its effectiveness in bleeding patients and CRASH 3 (1,5) (in my opinion) showed that we should also
JC: Can we give tranexamic acid (TXA) via the IM route? St Emlyn’s Read More
Our post on the CRASH-3 trial, an RCT examining the use of TXA in head injury, was arguably our most controversial of 2019 (1). Our view was that the evidence
JC: TXA in severe head injury. St Emlyn’s Read More
